Ericd Peterson News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Contact: Sarah Avery sarah.avery@duke.edu 919-660-1306 Duke University Medical Center DURHAM, N.C. – A large study addressing the effectiveness and safety of aldosterone antagonist therapy for older heart failure patients has found notable differences between the drug's results in clinical trial vs. what occurs in actual practice, according to researchers at Duke Medicine. Those differences have…

A home-based remote-care program reduced hypertension and lipid levels in a diverse patient population using a team approach.

The U.S. Preventive Services Task Force’s new recommendation statement on the use of statin therapy for primary prevention in adults aged 40 to 75 years with no history of CVD is similar to its 2016 recommendations.The USPSTF continues to recommend statins for the primary prevention of CVD in patients aged 40 to 75 years with at least one CVD risk factor and 10% or greater 10-year risk for

The new statement invites comparison with the more comprehensive 2018 ACC/AHA-multisociety statin guidelines. A slew of editorials across several journals do just that.

Though some see omissions, there are no great surprises in the task force’s advice, intended for a primary care audience.